Investing

Proceeds from other investments

Abbott Proceeds from other investments remained flat by 0.0% to $750.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 89.3%, from $7.00M to $750.00K. Over 4 years (FY 2021 to FY 2025), Proceeds from other investments shows a downward trend with a -55.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2025Feb 20, 2026

How to read this metric

An increase indicates successful liquidation of alternative assets, while a decrease suggests holding or reduced divestment activity.

Detailed definition

Cash inflows resulting from the sale, redemption, or maturity of non-marketable investment assets. This category typical...

Peer comparison

Common in large financial institutions and insurers with diversified alternative asset portfolios.

Metric ID: klac_proceeds_from_other_investments

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$77.00M$152.00M$43.00M$28.00M$3.00M
YoY Change+97.4%-71.7%-34.9%-89.3%
Range$3.00M$152.00M
CAGR-55.6%
Avg YoY Growth-24.6%
Median YoY Growth-53.3%
Current Streak3 years decline

Proceeds from other investments at Other Companies

Frequently Asked Questions

What is Abbott's proceeds from other investments?
Abbott (ABT) reported proceeds from other investments of $750.00K in Q4 2025.
How has Abbott's proceeds from other investments changed year-over-year?
Abbott's proceeds from other investments decreased by 89.3% year-over-year, from $7.00M to $750.00K.
What is the long-term trend for Abbott's proceeds from other investments?
Over 4 years (2021 to 2025), Abbott's proceeds from other investments has grown at a -55.6% compound annual growth rate (CAGR), from $77.00M to $3.00M.
What does proceeds from other investments mean?
Cash received from selling or maturing non-marketable investments.